CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $218,618,863
- in 14 filings, $45.5M under 10b5-1 plans
Net −$218,618,863. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Venker Eric President & Immunovant CEO | Sale 10b5-1 | −33,818 | $36.44 | $1.2M | 1,599,154 |
| 2026-08-21 | Sukhatme Mayukh President & CIO | Sale | −144,756 | $36.48 | $5.3M | 18,630,739 |
| 2026-08-20 | Sukhatme Mayukh President & CIO | Sale | −17,519 | $37.30 | $653K | 18,630,739 |
| 2026-08-19 | Sukhatme Mayukh President & CIO | Sale | −172,899 | $37.17 | $6.4M | 18,630,739 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Sale | −105,141 | $36.59 | $3.8M | 18,630,739 |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Sale | −31,801 | $37.18 | $1.2M | 18,630,739 |
| 2026-08-17 | Sukhatme Mayukh President & CIO | Sale | −284,707 | $36.25 | $10.3M | 18,630,739 |
| 2026-08-14 | Sukhatme Mayukh President & CIO | Sale | −243,177 | $36.23 | $8.8M | 18,630,739 |
| 2026-07-27 | Venker Eric President & Immunovant CEO | Sale 10b5-1 | −200,000 | $34.95 | $7.0M | 1,613,063 |
| 2026-06-30 | Fitzgerald Meghan Director | Sale 10b5-1 | −10,000 | $34.90 | $349K | 42,963 |
| 2026-06-30 | MANCHESTER KEITH S Director | Sale | −12,380 | $35.28 | $437K | 13,689,166 |
| 2026-06-30 | MANCHESTER KEITH S Director | Sale | −200,000 | $35.45 | $7.1M | 1,748,403 |
| 2026-06-30 | Gold Daniel Allen Director | Sale | −12,380 | $35.28 | $437K | 13,689,166 |
| 2026-06-30 | QVT Financial LP Director by Deputization | Sale | −12,380 | $35.28 | $437K | 13,689,166 |
| 2026-06-29 | Epperly Melissa B, Director | Sale 10b5-1 | −15,002 | $34.32 | $515K | 19,222 |
| 2026-06-29 | Epperly Melissa B, Director | Sale 10b5-1 | −2,748 | $34.71 | $95K | 16,474 |
| 2026-06-29 | MANCHESTER KEITH S Director | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | MANCHESTER KEITH S Director | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −200,000 | $34.44 | $6.9M | 14,301,546 |
| 2026-06-29 | Gold Daniel Allen Director | Sale | −600,000 | $34.59 | $20.8M | 13,701,546 |
Page 3 of 17 · 326 trades